Stocks and Investing Stocks and Investing
Wed, March 1, 2023

Luca Issi Maintained (ALLO) at Buy with Decreased Target to $22 on, Mar 1st, 2023


Published on 2024-10-28 02:00:30 - WOPRAI, Luca Issi
  Print publication without navigation


Luca Issi of RBC Capital, Maintained "Allogene Therapeutics, Inc." (ALLO) at Buy with Decreased Target from $32 to $22 on, Mar 1st, 2023.

Luca has made no other calls on ALLO in the last 4 months.



There are 4 other peers that have a rating on ALLO. Out of the 4 peers that are also analyzing ALLO, 0 agree with Luca's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Luca


  • Brian Cheng of "JP Morgan" Upgraded from Hold to Buy and Decreased Target to $11 on, Tuesday, January 24th, 2023
  • Jack Allen of "Baird" Upgraded from Hold to Buy and Held Target at $12 on, Friday, January 6th, 2023
  • Jason Gerberry of "B of A Securities" Downgraded from Strong Buy to Sell and Held Target at $9 on, Monday, December 12th, 2022
  • Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $29 on, Monday, November 21st, 2022
Contributing Sources